Rare diseases;Enfermedades raras

FMC Formacion Medica Continuada en Atencion Primaria

Volumn 14, Issue 5, 2007, Pages 236-244

  De La Paz, Manuel Posada ^a  

^a Instituto de Salud Carlos III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AGAMMAGLOBULINEMIA; ALBRIGHT SYNDROME; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; ATAXIA; AUTOSOMAL RECESSIVE DISORDER; DYSTONIA; EPIDERMOLYSIS BULLOSA; ERYTHRODERMA; GASTRITIS; GAUCHER DISEASE; GLYCOGEN STORAGE DISEASE TYPE 2; GUILLAIN BARRE SYNDROME; HEALTH PROGRAM; HUMAN; IMMUNE DEFICIENCY; MEDICAL INFORMATION; MEDICAL LITERATURE; MUSCULAR DYSTROPHY; NEUROPATHY; OSTEOGENESIS IMPERFECTA; PANCREATITIS; RARE DISEASE; SARCOIDOSIS; SCLERODERMA; SPINAL MUSCULAR ATROPHY; SYRINGOMYELIA; VASCULITIS; WILSON DISEASE;

EID: 34548100036     PISSN: 11342072     EISSN: 15789675     Source Type: Journal    
DOI: 10.1016/S1134-2072(07)71618-3     Document Type: Article

References (35)

1. Report of the National Commission on Orphan Diseases. Commission report (I): introduction. J Rare Diseases. 1996;2:21-7.
2. o 1295/1999/EC of the European Parliament and of the Council of 29 April 1999 adopting a programme of Community action on rare diseases within the framework for action in the field of public health (1999 to 2003). Disponible en: http://europa.eu.int/eurlex/pri/en/oj/dat/1999/l_155/ l_15519990622en00010005.pdf
3. Regulation (EC) N.o 141/2000 of the European Parliament and of the Council of 16 December 1999 on orphan medicinal products. Disponible en: http://eur-lex.europa.eu/LexUriServ/site/es/oj/2000/l_018/ l_01820000122es00010005.pdf
4. ORPHANET. Disponible en: http://www.orpha.net/
5. Servicio Andaluz de Salud. Consejería de Salud Versiones CIE9MC. Disponible en: http://www.juntadeandalucia.es/servicioandaluzdesalud/principal/ documentosAcc.asp?pagina=profesionales_cmbda_7
6. World Health Organization. International Statistical Classification of Diseases and Related Health Problems. 10th Revision. Version for 2006. Disponible en: http://www.who.int/classifications/apps/icd/icd10online/
7. Mauno Vihinen Institute of Medical Technology. Classification of Immunodeficiencies. Disponible en: http://dna.uta.fi/xml/idr/classification.xml
8. UCSD Biochemical Genetics List Inborn Errors of Metabolism with ICD-10 Codes and OMIM Links. Disponible en: http://biochemgen.ucsd.edu/Tools/
9. European Network for Rare Congenital Anaemias (ENERCA). Disponible en: http://www.enerca.org/
10. European Integrated Project on Spinocerebellar Ataxias: pathogenesis, genetics, animal models and therapy. Disponible en: http://www.eurosca.org/
11. Online Mendelian Inheritance in Man (OMIM). Disponible en: http://www.ncbi.nlm.nih.gov/Omim/
12. National Institutes of Health. Office for Rare Diseases. Rare Diseases Terms. Disponible en: http://rarediseases.info.nih.gov/asp/diseases/diseases.asp
13. o 5.
14. Gaite L, Cantero P, González-Lamuño D, García Fuentes M. Necesidades de los pacientes pediátricos con enfermedades raras y de sus familias en Cantabria. Madrid: Real Patronato sobre Discapacidad. Ministerio de Trabajo y Asuntos Sociales; 2005. Documento 69.
15. Taruscio D, Cerbo M. Rare diseases: general principles, specific problems and public health policies. Ann Inst Sup Sanitá. 1999;35:237-44.
16. DG Research. European Commission. Sixth framework programme: Life sciences, genomics and biotechnology for health. Disponible en: http://europa.eu.int/scadplus/leg/en/lvb/i23013.htm
17. DG Health and Consumer Protection Programme of Community action in the field of public health (2003-2008). Disponible en: http://ec.europa.eu/health/ ph_programme/programme_en.htm
18. Rare Diseases Task Force. Disponible en: http://www.orpha. net/testor/cgi-bin/OTmain.php
19. DG Health and Consumer Protection. Public Health. Rare diseases. Disponible en: http://ec.europa.eu/health/ph_threats/non_com/rare_diseases_en. htm
20. Conferencia Europea sobre Enfermedades Raras 2005. Disponible en: http://www.eurordis.org/IMG/pdf/ES-ECRDtotal.pdf
21. Ministerio de la Salud y de la Protección Social. Plan Nacional Francés para las Enfermedades Raras 2005-2008. Asegurar la equidad para el acceso al diagnóstico, a los tratamientos y a la atención. Disponible en: http://www.eurordis.org/IMG/pdf/ SN_plan_nacional_frances_enfermedades_raras.pdf
22. Federación Española de Enfermedades Raras (FEDER). Disponible en: http://www.enfermedades-raras.org/es/default.htm
23. EURORDIS: European Organisation for Rare Diseases. Disponible en: http://www.eurordis.org/
24. Ministerio de Sanidad y Consumo. REAL DECRETO 1302/2006, de 10 de noviembre, por el que se establecen las bases del procedimiento para la designación y acreditaciónde los centros, servicios y unidades de referencia del Sistema Nacional de Salud. BOE, 11 de noviembre de 2006;270:39503-5.
25. Heyworth BE, Su EP, Figgie MP, Acharya SS, Sculco TP. Orthopedic management of hemophilia. Am J Orthop. 2005;34:479-86.
26. Buckley RH. A historical review of bone marrow transplantation for immunodeficiencies. J Allergy Clin Immunol. 2004;113:793-800.
27. Ross M, Kouretas P, Gamberg P, Miller J, Burge M, Reitz B, et al. Ten- and 20-year survivors of pediatric orthotopic heart transplantation. J Heart Lung Transplant. 2006;25:261-70.
28. Schachna L, Medsger TA Jr, Dauber JH, Wigley FM, Braunstein NA, White B, et al. Lung transplantation in scleroderma compared with idiopathic pulmonary fibrosis and idiopathic pulmonary arterial hypertension. Arthritis Rheum. 2006;54:3954-61.
29. Bick DP, Lau EC. Preimplantation genetic diagnosis. Pediatr Clin North Am. 2006;53:559-77.
30. Commission of the European Communities. Commission Staff Working Document on the experience acquired as a result of the application of Regulation (EC) No 141/2000 on orphan medicinal products and account of the public health benefits obtained Document on the basis of Article 10 of Regulation (EC). Brusells, 20 Jun 2006. Disponible en: http://ec.europa. eu/enterprise/pharmaceuticals/ orphanmp/doc/orphan_en_06-2006.pdf
31. European Medicines Agency (EMEA). Points to consider on the calculations and reporting of prevalence of a condition for orphan designation. London, 26 Mar 2002. COMP/436/01. Disponible en: http://www.emea.eu.int/pdfs/human/comp/ 043601.pdf
32. European Commission. Enterprise and Industry. Register of designated Orphan Medicinal Products. Disponible en: http://ec.europa.eu/enterprise/ pharmaceuticals/register/orphreg.htm
33. European Organisation for Rare Diseases (EURORDIS). EURORDIS surveys of orphan drugs: availability and prices in EU Member States. October 2002-January 2003. Disponible en: http://www.eurordis.org/IMG/pdf/omp_availability_europe02- 03_20report.pdf
34. Portal de la Red de Investigación de Enfermedades Raras (REpIER). Disponible en: http://repier.retics.net/repier/home.aspx
35. Pandor A, Eastham J, Beverley C, Chilcott J, Paisley S. Clinical effectiveness and cost-effectiveness of neonatal screening for inborn errors of metabolism using tandem mass spectrometry: a systematic review. Disponible en: http://www.ncchta.org/execsumm/summ812.htm